New Kratom regulation bill introduced by Ohio state representative

16 August 2019
New Kratom regulation bill introduced by Ohio state representative

COLUMBUS, OH (WCMH)– Four days after the Ohio Board of Pharmacy decided to delay a decision on a proposal to classify kratom as a Schedule 1 controlled substance, a bill to regulate the substance was introduced in the Ohio House of Representatives.


  • Pharmacy board delays decision on Kratom
  • Kratom shop owner nervous awaiting pharmacy board decision 

    Central Ohio State Rep. Gary Scherer (R-Circleville) introduced House Bill 318 regarding the sale of kratom Tuesday to learn more about the plant and its uses.

    “My purpose for introducing this bill is to continue the discussion. Frankly at this point, I don’t know if I would vote for the bill myself, but I think it warrants further study, and we’ll see where that study goes,” Scherer stated in a Facetime interview.

    The bill would regulate and would make a requirement that anyone selling kratom knows its origin and has been through testing to make sure it’s the pure product.


    Scherer added that he is pleased the board of pharmacy decided to delay their vote.

    “I appreciate that they did decide to listen to the people giving testimony, and they voluntarily put it into a future discussion status.” continued Scherer. “I commend them, and I appreciate them and want to continue to work with them on this.”

    The representative says until about six weeks ago, he had never heard of kratom. He learned about it from his friend Utah State Senator Curt Bramble. Utah along with Georgia, Arizona, and Nevada have kratom consumer protection laws similar to Ohio HB 318.

    Bramble believes the use of kratom over opioids could help slow the overdose epidemic across the country.

    “That’s what Sen. Bramble, my good friend from Utah, has talked about in his personal life,” Scherer explained. “He comes to it with a great passion. The opioid epidemic has impacted his family in a huge way. His son-in-law died from an overdose, and Curt believes that if this product had been available and they had known about it, maybe they could have gotten his son-in-law off of the addiction.”

    Six months ago NBC4 reported on a study a study published by the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital that found a dramatic increase in calls to U.S. poison control centers for kratom exposure, and highlighted the need to educate pregnant women on the dangers.

    PREVIOUS STORY: Kratom study shows risk of neo-natal withdrawal, drastic increase in calls to poison control centers

    The American Kratom Association says that it was written based on bad science, and when used properly, the quality of life for those who treat ailments with kratom rather than opioids or other pharmaceutical drugs improves.

    PREVIOUS STORY: Kratom advocate says substance is saving lives

    Scherer wants the science and testimony from both sides to come forward during bill debate.

    “I’m particularly moved by [the NCH report] that would be in favor a scheduling kratom,” he elaborated. “I want to hear from experts, and I want to hear from people that are using [kratom] and try to determine whether it is safe or not. It seems like the issues with it that resulted in some fatalities have been not with the pure product [but with] the adulterated product. Things like fentanyl put in, that we obviously know the catastrophic effects of that.”

    The American Kratom Association sent NBC4 the following statement in response to the introduction of the kratom bill:The American Kratom Association (AKA) applauds the decision by Ohio Representative Gary Scherer to file the Kratom Consumer Protection Act that will add a needed layer of protection for consumers from adulterated kratom products that are harming consumers. AKA advocates for consumer protections that allow consumers the freedom to make their own choices on their health and well-being, and kratom has been unfairly demonized by the FDA.  The states of Utah, Georgia, Arizona, and Nevada have overwhelmingly passed the Kratom Consumer Protection Act that prohibits dangerous adulterants that harm consumers. Additionally, new science funded by the National Institutes on Drug Abuse (NIDA) has concluded that there is no significant addiction liability to the use of kratom, and those studies support reports from some kratom consumers that kratom helps them reduce opioid use, and in many cases use kratom as an alternative to opioids. In that context, kratom saves lives and banning it would mean more opioid deaths. Ohio’s citizens will benefit greatly from the passage of the Kratom Consumer Protection Act.


    CLICK HERE to read the bill in its entirety.

    Kratom regulation bill introduced by Ohio State Representative Gary Scherer. Do you have any questions about kratom or the bill? READ MORE ??

    Posted by NBC4 on Wednesday, August 14, 2019

To overview

This website uses cookies to ensure you get the best experience on our website. Read more about our Cookie Policy.